AX-15836

2035509-96-5

C32H40N8O5S

DMSO : >= 101 mg/mL (155.68 mM)

Stem Cell/Wnt; MAPK/ERK Pathway

AX-15836 is a potent and selective ERK5 inhibitor with an IC₅₀ of 8 nM. IC50 & Target: IC50: 8 nM (ERK5)^[1] In Vitro: AX-15836 shows more than 1, 000-fold selectivity for ERK5 over a panel of over 200 kinases. It also exhibits selectivity over BRD4 with a K_d of 3, 600 nM. AX15836 shows similar intracellular potency (4�9 nM) across all cells tested, including peripheral blood mononuclear cells (PBMCs), endothelial cells, and oncogenic cell lines. AX15836 was completely ineffective (EC₅₀>10 uM) to suppress inflammatory cytokine response, suggesting that it was the BRD inhibition component of the compounds that mediated cytokine reduction. In HUVEC and HeLa cell types, samples treated with AX15836 shows very few genes to be differentially expressed. AX15836 could clearly inhibit the EGF-stimulated, phosphorylated form of ERK5 in HeLa cells^[1].